Laura Helminen
Väitöskirjatutkija
FM (molekyylilääketiede); bioanalyytikko (AMK)
Biolääketieteen yksikkö, Lääketieteen laitos, Terveystieteiden tiedekunta
laura.helminen@uef.fi
Julkaisut
4/4 kappaletta-
EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells
Huttunen, Jasmin; Aaltonen, Niina; Helminen, Laura; Rilla, Kirsi; Paakinaho, Ville. 2024. Cellular and molecular life sciences. 81: . 160 -
Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer
Helminen, Laura; Huttunen, Jasmin; Tulonen, Melina; Aaltonen, Niina; Niskanen, Einari A; Palvimo, Jorma J; Paakinaho, Ville. 2023. Nucleic acids research. 2024; 52: 625-642 -
N/C Interactions Are Dispensable for Normal In Vivo Functioning of the Androgen Receptor in Male Mice
El Kharraz, Sarah; Dubois, Vanessa; Launonen, Kaisa-Mari; Helminen, Laura; Palvimo, Jorma J; Libert, Claude; Smeets, Elien; Moris, Lisa; Eerlings, Roy; Vanderschueren, Dirk; Helsen, Christine; Claessens, Frank. 2022. Endocrinology. 163: . bqac104 -
The androgen receptor depends on ligand-binding domain dimerization for transcriptional activation
El Kharraz, Sarah; Dubois, Vanessa; Royen, Martin E; Houtsmuller, Adriaan B; Pavlova, Ekatarina; Atanassova, Nina; Nguyen, Tien; Voet, Arnout; Eerlings, Roy; Handle, Florian; Prekovic, Stefan; Smeets, Elien; Moris, Lisa; Devlies, Wout; Ohlsson, Claes; Poutanen, Matti; Verstrepen, Kevin J; Carmeliet, Geert; Launonen, Kaisa-Mari; Helminen, Laura et al [incl. Palvimo, Jorma J]. 2021. Embo reports. 22: e52764